NCT02290873 - A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients | Biotech Hunter

Enrollment

461

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 19, 2016

Conditions

Colonoscopy

Interventions

DRUG

Remimazolam

For induction and maintenance of sedation

DRUG

Midazolam

For induction of maintenance and sedation

DRUG

Placebo

Inactive control arm

Trial Locations (13)

19107

Thomas Jefferson Medical College, Philadelphia

23320

Gastroenterology Associates of Tidewater, Chesapeake

27612

Wake Research Associates, Raleigh

32256

Borland-Grover Clinic, P.A, Jacksonville

36688

University of South Alabama, Mobile

37205

Nashville Medical Research Institute, Nashville

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University Health, Indianapolis

63110

Washington University School of Medicine, St Louis

71201

Delta Research Partners Inc, Monroe

91910

Precision Research Institute, Chula Vista

92114

Precision Research Institute, San Diego

92801

Advanced Clinical Research Institute, Anaheim